COVID-19’s return is not just as a virus, but as a mirror, reflecting who we are, what we believe, and how easily a nation can be pulled between science and suspicion.
The moment the news broke that fresh infections quietly threading their way back into Nigeria, it did more than alert public health officials. It awakened something deeper, something familiar. A restless undercurrent of cynicism, doubt, conspiracy, and myth, those recurring characters in Nigeria’s national story. These rose again, as if they had only been waiting for the next cue. The virus may have waned, but the narratives around it never truly left.

For me, the worry is not merely about the infection itself, but about the pattern it threatens to repeat. History in global health has shown through diseases like HIV/AIDS that advanced nations often move ahead, containing and managing outbreaks with speed and precision, while developing countries are left to wrestle with the long tail of consequences for decades. Scholars in global health inequality have long argued that pandemics do not just expose biological vulnerabilities, but structural ones. These are what health inequity theorists describe as the uneven distribution of resources, trust, and institutional capacity. In this light, the real danger is not just the virus returning, but the possibility that distrust and politicization will once again sabotage planning, weaken policy, and entrench the disease as a stubborn endemic.

The story itself began almost quietly, a Chinese national in Cross River State showing symptoms, followed by the identification of ten close contacts, swiftly isolated. The state’s epidemiologist, Dr. Inyang Ekpenyong, led contact tracing efforts, visiting the individual’s workplace in Akamkpa, while treatment commenced at the University of Calabar Teaching Hospital. The machinery of public health, at least on paper, moved as expected: isolation, tracing, communication.

Officials reassured the public, reminding them that COVID-19 had never truly disappeared, only receded into a more manageable phase. Preventive measures such as masks, hygiene, vigilance were once again emphasized, echoing a script the world had rehearsed for years. Yet, almost immediately, another script took over, the public’s.

As the news spread, so did memory. But memory in Nigeria is rarely neutral; it is selective, emotional, and often shaped by what psychologists describe as confirmation bias, the tendency to embrace information that aligns with pre-existing beliefs while dismissing what does not. The relatively low mortality recorded during the first wave in Nigeria, compared to catastrophic outcomes in parts of Europe and America, had already planted seeds of doubt. To many, the pandemic felt exaggerated, distant, or even suspicious. And so, the return of COVID-19 was not met with uniform concern, but with a chorus of skepticism.

One voice among many online captured this sentiment bluntly: a refusal to take vaccines, a rejection of official narratives, and a firm belief that COVID-19 was engineered in a laboratory to serve economic interests. It is a powerful narrative,not because it is proven, but because it is persuasive. It taps into distrust of institutions, suspicion of global power structures, and the deeply human instinct to “follow the money.”

Here is where theory meets reality. Sociologists like Ulrich Beck, in his concept of the “risk society,” argue that modern societies are increasingly defined not just by risks themselves, but by how those risks are perceived and contested. In such societies, scientific authority no longer goes unquestioned; instead, it competes with alternative interpretations, political interests, and personal beliefs. Nigeria’s COVID-19 discourse fits squarely into this framework, a battleground of competing truths.

The invocation of political figures such as Yahaya Bello further illustrates this dynamic. His past dismissal of COVID-19 and rejection of vaccines, the positions that stood in stark contrast to the overwhelming consensus of health experts have now been resurrected, not necessarily because of their credibility, but because they resonate with certain segments of the population. Ironically, many who now cite him as validation were never his supporters. This is not about loyalty; it is about alignment. When a statement echoes what people already feel, it gains power, regardless of its origin. This reflects what communication scholars describe as the “echo chamber effect,” where beliefs are reinforced through repetition within like-minded circles.

The same pattern played out with Okezie Ikpeazu, whose earlier skepticism, followed by his own infection, underscores the complex interplay between belief and reality. Even when contradictory evidence emerges, initial narratives often persist, reshaped but rarely abandoned.

Against this backdrop, the challenge thrown to “go and research” the origins of COVID-19 appears, at first glance, like a call to rational inquiry. But research itself is not immune to interpretation. What emerges from credible scientific literature is not a definitive answer, but a nuanced one: the origin of SARS-CoV-2 remains uncertain. Both natural spillover and laboratory-related scenarios are still under investigation, with no conclusive evidence firmly establishing either. This uncertainty, however, is often misunderstood. In science, uncertainty is not weakness; it is honesty. Yet in public discourse, it is frequently exploited to advance definitive, but unsupported claims.

The reference to gain-of-function research adds another layer of complexity. Yes, such research exists. Yes, it involves modifying viruses to better understand their behavior. And yes, funding for coronavirus research did involve international collaborations, including institutions in Wuhan. But as research methodology experts emphasize, the existence of a process does not prove its misuse. The leap from “this research exists” to “this specific virus was created through it” is not evidence-based, it is inferential, and often speculative.

On vaccines, however, the picture is clearer. The overwhelming body of evidence supports their effectiveness in reducing severe illness and death. The shift in Nigeria from mass vaccination campaigns to integration into routine healthcare reflects a transition from crisis response to long-term management. Immunity, as immunologists explain through the framework of hybrid immunity, is now shaped by both vaccination and prior infection, offering broader, though not permanent, protection.

Still, the persistence of new infections reminds us that herd immunity remains elusive. Epidemiological models show that as viruses evolve, becoming more transmissible, the threshold for herd immunity shifts upward, often beyond practical reach. COVID-19, like influenza, is settling into an endemic pattern: present, recurring, but largely manageable.

And yet, beneath all these layers of science, policy, history lies a more uncomfortable truth. The struggle is not only against the virus, but against ourselves. When citizens selectively trust information, when leaders amplify unverified claims, and when public discourse prioritizes emotion over evidence, the consequences extend far beyond COVID-19. They shape how a nation responds to every future crisis.
It is not new. The memory of statements like that of Abdulaziz Yari, attributing meningitis to moral failings rather than medical causes, lingers as a reminder of how easily misinformation can be legitimized when it comes from authority. When such voices become reference points, confusion is no longer accidental, it becomes systemic.

So, what does it mean for COVID-19 to return to Naija?

It means the virus is back, but more importantly, the conversation is back. The tension between science and suspicion, evidence and emotion, leadership and followership, has resurfaced. And perhaps the real test is no longer whether Nigeria can contain a virus, but whether it can confront the deeper contagion of distrust that shapes how that virus is understood.

Bagudu can be reached via bagudumohammed15197@gmail.com or 07034943575.